<sub>Metabolic</sub> shift to serine pathway induced by lipids confers oncogenic properties in non-transformed breast cells
Mariana Bustamante Eduardo(Northwestern University), Susan E. Clare(Northwestern University), María Paula Zappia(University of Illinois Chicago), Curtis W. McCloskey(University Health Network), Maxim V. Frolov(Northwestern University), Rama Khokha(University Health Network), Navdeep S. Chandel(Northwestern University), Jason W. Locasale(Duke University), Hongyu Gao(Indiana University School of Medicine), Peng Gao(Northwestern University), Elizaveta V. Benevolenskaya(University of Illinois Chicago), Seema A. Khan(Northwestern University), Gannon Cottone(Northwestern University), Flávio R. Palma(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Joel Setya(Northwestern University), Shiyu Liu(Air Force Medical University), Xiaoling Xuei(Indiana University Health), A.B.M.M.K. Islam(University of Illinois Chicago), Marcelo G. Bonini(Northwestern University)
Cited by 1
Related Papers
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
|Nature Genetics|2011|1.1k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717